Breaking News - The Fly

Open Search

TVTX

Travere Therapeutics

$

()

Travere Therapeutics price target raised by $2 at H.C. Wainwright, here's why

TVTX

4/24/2024 - 12:27pm

Travere Therapeutics, CSL Vifor announce EC approves FILSPARI

TVTX

4/24/2024 - 07:10am

Travere Therapeutics, CSL Vifor announce EC approval for Filspari

TVTX

4/24/2024 - 05:21am

Travere downgraded to Neutral at Guggenheim on smaller role in IgAN space

TVTX

3/27/2024 - 09:24am

Guggenheim gets more bearish on Travere Therapeutics, downgrades shares

TVTX

3/27/2024 - 06:43am

Travere Therapeutics submits sNDA for FILSPARI for IgAN

TVTX

3/11/2024 - 07:42am

Travere Therapeutics price target lowered by $3 at H.C. Wainwright, here's why

TVTX

2/23/2024 - 10:23am

Travere , CSL Vifor announce Sparsentan received positive CHMP opinion

TVTX

2/23/2024 - 07:09am

Travere Therapeutics, CSL Vifor get CHMP recommendation for sparsentan approval

TVTX

2/23/2024 - 05:14am

Travere Therapeutics price target raised by $4 at Citi, here's why

TVTX

2/16/2024 - 17:23pm

Travere Therapeutics reports Q4 EPS (94c), consensus ($1.22)

TVTX

2/15/2024 - 16:12pm

Travere in $120M licensing deal with Renalys to develop sparsentan in Asia

TVTX

1/25/2024 - 16:25pm

Travere Therapeutics price target raised by $3 at TD Cowen, here's why

TVTX

1/25/2024 - 07:37am

Travere Therapeutics price target raised by $1 at Piper Sandler, here's why

TVTX

1/18/2024 - 07:35am

Travere Therapeutics announces anticipated 2024 milestones

TVTX

1/8/2024 - 07:41am